Dr. Zuhier Awan
Fellowship in Cardiovascular Genetics and a fellowship in Preventive Cardiology and Advanced Clinical Lipidology
Saudi Arabia
Director and Consultant of the Hyperlipidemia Clinic at King AbdulAziz University
Dr. Awan, MD, MBA, MSc, PhD, FACB, FNLA, FRCPC, FAHA, FACE, MedEdu; is an academic staff and a physician-scientist at King Abdulaziz University and the Research Institute of the McGill University Health Centre.
Dr. Awan received his medical degree from King Abdulaziz School of Medicine, and then completed residency training in both Internal Medicine and Medical Biochemistry at McGill University. Dr. Awan further completed a postdoctoral fellowship in Cardiovascular Genetics and a fellowship in Preventive Cardiology and Advanced Clinical Lipidology at the Cardiology Department of the Royal Victoria Hospital.
Dr. Awan is a fellow of the Royal College of Physicians and Surgeons of Canada, American Academy of Clinical Biochemistry, American Heart Association and American College of Endocrinology. He is both Canadian Board Certified (as Medical biochemist and Clinical Investigator) and American Board Certified in Clinical Lipidology. He also received a specialized training in Medical Education and Forensic Toxicology in the United States.
Dr. Awan earned both a M.Sc and Ph.D degrees with excellence from the Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal and did his thesis in the Proprotein Convertase Subtilisin / Kexin Type 9 and the Prevention of Cardiometabolic Disease in Familial Hypercholesterolemia.
Dr. Awan's research interests are in:
- Familial Hypercholesterolemia (FH) management.
- Cardiovascular disease prevention and randomized clinical trials.
- Metabolic syndrome, DM and lipoprotein disorders.
- Proprotein convertases (PCSK9) in human diseases.
- Cellular biology, genetics and bioinformatics.
Specialties:
- Preventive Cardiology.
- Clinical Lipidology and Endocrinology.
- Clinical Biochemistry and Molecular Medicine.